Related Experiment Video
Updated: Apr 5, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Splicing Regulators and Their Roles in Cancer Biology and Therapy
Maria Roméria da Silva1, Gabriela Alves Moreira1, Ronni Anderson Gonçalves da Silva1
1Departamento de Bioquímica e Biologia Molecular, Universidade Federal de Viçosa, 36570-900 Viçosa, MG, Brazil.
Abstract:
Alternative splicing allows cells to expand the encoding potential of their genomes. In this elegant mechanism, a single gene can yield protein isoforms with even antagonistic functions depending on the cellular physiological context. Alterations in splicing regulatory factors activity in cancer cells, however, can generate an abnormal protein expression pattern that promotes growth, survival, and other processes, which are relevant to tumor biology. In this review, we discuss dysregulated alternative splicing events and regulatory factors that impact pathways related to cancer. The SR proteins and their regulatory kinases SRPKs and CLKs have been frequently found altered in tumors and are examined in more detail. Finally, perspectives that support splicing machinery as target for the development of novel anticancer therapies are discussed.
Insights
Alternative splicing generates diverse proteins from single genes. In cancer, altered splicing factors create abnormal proteins, driving tumor growth, and highlighting splicing as a therapeutic target.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Biology
Background:
- Alternative splicing expands the proteome from a limited genome.
- Splicing patterns are context-dependent, yielding proteins with varied functions.
- Aberrant splicing in cancer contributes to tumor progression.
Purpose of the Study:
- To review dysregulated alternative splicing in cancer.
- To examine key regulatory factors like SR proteins and their kinases (SRPKs, CLKs).
- To discuss the potential of targeting the splicing machinery for cancer therapy.
Main Methods:
- Literature review of alternative splicing in cancer.
- Focus on SR proteins, SRPKs, and CLKs.
- Analysis of splicing's role in cancer pathways.
Main Results:
- Dysregulated alternative splicing is prevalent in cancer.
- SR proteins and associated kinases are frequently altered in tumors.
- Altered splicing promotes cancer cell growth and survival.
Conclusions:
- Splicing machinery is a critical player in tumor biology.
- Targeting splicing represents a promising avenue for novel anticancer therapies.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

